Archive

New UMaine research could help lower prescription drug costs

Written by | 30 Sep 2025

One of the main factors driving prices in pharmaceuticals, such as cholesterol-lowering drugs and antibiotics, is the cost of production and materials. Researchers at the University of Maine […]

EMA Annual Report: 114 new medicines in 2024

Written by | 27 Jun 2025

The European Medicines Agency (EMA) – the EU’s drug safety watchdog – approved 114 medicines last year, with 46 of these having a new active substance which had […]

Smartphone tests could accelerate drug development for Huntington’s disease

Written by | 17 Jun 2025

A series of digital tests, carried out via a smartphone app, could enhance the detection of disease progression in Huntington’s disease and improve the efficiency of clinical trials, […]

Purdue center offers first comprehensive open access database of all clinically tested drugs

Written by | 2 Jun 2025

Purdue University’s College of Pharmacy is now home to the Center for Research Innovation in Biotechnology and the Clinical Drug Experience Knowledgebase, a comprehensive database of every active pharmaceutical ingredient with evidence of […]

Faster drug development with the help of artificial intelligence

Written by | 26 Jan 2025

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in the early phase of drug development – still largely relies […]

Discovery could eliminate need to refrigerate vaccines and protein-based drugs

Written by | 22 Jan 2025

A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by  researchers at Penn State, could eliminate the need for […]

Typical cost of developing new pharmaceuticals is skewed by high-cost outliers

Written by | 10 Jan 2025

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical […]

Tirzepatide shows powerful diabetes-prevention effect in three-year trial

Written by | 2 Dec 2024

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a […]

85% of Americans want animal experiments phased out, new survey shows

Written by | 6 Oct 2024

A new survey shows that Americans’ attitudes toward experiments on animals have changed significantly in recent years, with the vast majority now favoring phasing out animal experiments in […]

Ontario Institute for Cancer Research funding aims to speed the development of new drugs for some of the most common cancers

Written by | 4 Oct 2024

The Ontario Institute for Cancer Research (OICR) continues to support Ontario drug discovery research by funding high-quality investigations of new therapies for some of the most prevalent pediatric […]

It’s the most common STI you’ve never heard of. Will this newly developed drug provide the cure?

Written by | 1 Sep 2024

Researchers at Tulane University are leading a groundbreaking study to seek a more effective treatment for trichomoniasis, an infection that, despite being the most common curable sexually transmitted […]

Biotechnology companies can sustain the pipeline of new drugs under the Inflation Reduction Act

Written by | 27 Jul 2024

New research from the Center for Integration of Science and Industry at Bentley University shows that differences between the financial structures of large pharmaceutical producers and smaller, emerging biotechnology companies creates synergies […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.